Learn / Clinical Research Management / Conducting the trial at the site
Investigational product management
12 minute read · 6-question quiz
What you will learn
Describe the chain of custody and accountability for investigational product (IP)
Explain storage, temperature control and excursions
Handle blinding, randomisation and returns or destruction
The investigational product (IP) is the medicine, vaccine, device or placebo being tested or used as a comparator. Careful management ensures participants receive the correct, safe, effective product and that data about dosing can be trusted.
Chain of custody
From the manufacturer to the participant, every handover must be recorded: shipment, receipt, storage, dispensing, return and destruction. Each step has a responsible person, a date and a quantity, so that every unit is accounted for.
Key responsibilities at the site
- Receipt: check the shipment against the packing list, check condition and temperature data loggers, and record receipt. Quarantine suspect shipments until the sponsor confirms they are usable.
- Storage: keep in a secure, locked area with access limited to authorised staff and at the labelled temperature (for example 2 to 8 degrees Celsius or room temperature). Use calibrated thermometers or continuous loggers with alarms.
- Dispensing: according to the protocol and randomisation, by trained delegated staff.
- Accountability: keep a log of quantities received, dispensed, returned and remaining. Reconcile regularly.
- Returns and destruction: return unused product to the sponsor, or destroy it as instructed, with documentation.
Temperature excursions
An excursion happens when product is stored outside its permitted temperature range. Staff must:
- Quarantine the affected product (do not dispense).
- Record the duration and temperatures.
- Notify the sponsor or CRO at once.
- Wait for written instructions on whether the product can still be used.
Randomisation, blinding and unblinding
- Randomisation allocates participants by chance, usually through a central system or sealed numbered packs, so that the groups are comparable.
- Allocation concealment hides the next assignment from those enrolling participants. Blinding hides the assignment from participants and staff after allocation.
- Emergency unblinding is permitted only when knowing the treatment is essential for the participant's safety. The reason is documented, and the sponsor is notified.
Summary
Every handover of IP is recorded from manufacturer to destruction.
Storage must be secure and within the labelled temperature; excursions are quarantined and reported.
Accountability logs are reconciled regularly.
Unblinding is only for safety reasons and is documented.
Check your understanding
Draft study guide. Spotted an error or something unclear? Tell us at hello@scintria.com. This is educational material, not clinical or regulatory advice.